Table 3.
Averted measles burden (in thousands) following the introduction of MR-MAPs
| Projection assumption | Higher coverage | Lower coverage | ||||||||||
| Introduction strategy | Sequential | Accelerated | Sequential | Accelerated | ||||||||
| Measurement | Cases | Deaths | DALYs | Cases | Deaths | DALYs | Cases | Deaths | DALYs | Cases | Deaths | DALYs |
| Low income | 1076 (20.4%) |
11.4 (22.6%) |
742 (22.2%) |
1116 (21.1%) |
11.3 (22.5%) |
739 (22.1%) |
13 004 (36.7%) |
164 (38.3%) |
11 075 (38.6%) |
14 465 (40.8%) |
176 (41.2%) |
11 851 (41.3%) |
| Lower middle income | 5000 (34.2%) |
38.1 (27.0%) |
2494 (28.6%) |
5452 (37.3%) |
43.4 (30.8%) |
2815 (32.3%) |
16 905 (26.5%) |
218 (31.9%) |
13 612 (31.7%) |
23 063 (36.2%) |
220 (32.1%) |
14 014 (32.7%) |
| Upper middle income | 887 (61.9%) |
2.85 (50.7%) |
185 (50.7%) |
884 (61.7%) |
2.83 (50.4%) |
184 (50.4%) |
1350 (20.8%) |
7.70 (21.7%) |
517 (21.9%) |
1094 (16.9%) |
5.88 (16.6%) |
395 (16.8%) |
| Total | 6963 (32.7%) |
52.3 (26.6%) |
3420 (27.5%) |
7452 (35.0%) |
57.6 (29.2%) |
3737 (30.1%) |
31 259 (29.6%) |
390 (34.0%) |
25 204 (34.1%) |
38 623 (36.5%) |
402 (35.0%) |
26 260 (35.5%) |
Numbers represent the absolute cases, deaths and DALYs averted in thousands. Percentages in the brackets show the relative burden reduction compared with the scenarios without MR-MAPs.
DALY, disability-adjusted life-year; MR-MAP, measles-rubella microarray patch.